Adult migraine research links anxiety and depressive symptoms with greater disruption to daily activities. One large study found greater headache-related disability even after accounting for headache frequency and other measured factors. Another found greater burden both during and between attacks. People reporting both anxiety and depressive symptoms generally had stronger associations with burden than those reporting either alone.
These findings show associations, not proof that one condition causes another. For adults in Massachusetts, they offer context for understanding migraine's daily impact, not an individual prediction, diagnosis or estimate of how common these conditions are locally.
What the CaMEO study found about daily disability
The Chronic Migraine Epidemiology and Outcomes study analysis, known as CaMEO, included 16,788 adults who met survey-based migraine criteria. Participants came from an internet research panel. Their average age was 41; 74.4% were women and 84.0% were white. Although the larger CaMEO project followed participants over time, this particular analysis was cross-sectional: it examined relationships within a set of survey measurements rather than establishing a sequence of events.
Researchers assessed depression and anxiety using the nine-item Patient Health Questionnaire and seven-item Generalized Anxiety Disorder Scale. They grouped respondents into depression alone, anxiety alone, both or neither. These were classifications based on validated screening questionnaires. They should not be read as equivalent to every participant receiving an individual clinical diagnosis.
Headache-related disability was measured with the Migraine Disability Assessment Scale, or MIDAS. Its scored items address days when migraine prevented or limited work and nonwork activities over the previous three months. This captures both being unable to participate and participating with reduced function.
After adjustment for headache frequency and other measured characteristics, the study reported these relative increases in moderate or severe migraine-related disability compared with neither condition:
- Depression alone was associated with a 56% increase.
- Anxiety alone was associated with a 39% increase.
- Coexisting depression and anxiety were associated with a 79% increase.
Those are relative comparisons between study groups, not the percentage of all participants who became disabled. A 79% relative increase does not mean that 79 out of every 100 people with both symptom patterns will experience severe disability. The finding is that headache frequency alone did not account for the observed differences in daily impact.
What research shows about burden between attacks
Migraine burden is not limited to the activities disrupted during a headache. The Headache Assessment via Digital Platform in the United States study abstract, known as HeAD-US, examined both migraine-related disability and interictal burden. “Interictal” means between attacks. Measuring this separately allows researchers to examine an aspect of migraine burden that an attack-focused measure may not fully describe.
The study used cross-sectional data from 6,267 participants with migraine recruited through the Migraine Buddy app. Their average age was 41.5, and 90.8% were women. Researchers used MIDAS for disability, the Migraine Interictal Burden Scale, or MIBS, for between-attack burden, and the four-item Personal Health Questionnaire to assess anxiety and depressive symptoms.
In adjusted analyses, anxiety symptoms alone were associated with 8.7% higher MIDAS scores and 11.7% higher MIBS scores. Depressive symptoms alone were associated with increases of 28.4% and 15.5%, respectively. Having both symptom types was associated with 32.5% higher MIDAS scores and 22.6% higher MIBS scores.
These results extend the association beyond disability measured through disrupted activities: emotional symptoms were also associated with greater measured burden between attacks. However, the retained abstract does not describe individual experiences in enough detail to say exactly what that burden looked like for a particular participant. It also does not establish why the score differences occurred or whether changing emotional symptoms would change those scores.
Episodic and chronic migraine: meaningful group differences
The CaMEO paper describes chronic migraine as at least 15 headache days per month over the preceding three months, with migraine features on at least eight days monthly. Its survey classification used an average of at least 15 monthly headache days over the preceding three months. The analysis included 1,476 respondents classified with chronic migraine and 15,312 with episodic migraine.
Screening-based depression and anxiety were more common in the chronic migraine group:
| Screening category | Episodic migraine | Chronic migraine |
|---|---|---|
| Depression, including coexisting anxiety | 30.0% | 56.6% |
| Anxiety, including coexisting depression | 28.1% | 48.4% |
| Both depression and anxiety | 20.8% | 42.0% |
The first two rows overlap because each includes people with both conditions; the rows should not be added together. These figures describe the CaMEO respondents, not Massachusetts residents generally. They also do not mean that chronic migraine necessarily includes depression or anxiety, or that episodic migraine has little daily impact.
HeAD-US likewise reported more coexisting anxiety and depressive symptoms in chronic than episodic migraine: 30.3% versus 20.0%. The percentages differ from CaMEO, but the studies used different recruitment methods and screening instruments. Their estimates should remain attached to their own samples rather than being treated as interchangeable measurements.
How to interpret the evidence without overstating it
The studies point in a similar direction, but their designs set important boundaries. Large samples make it possible to examine patterns across many respondents. They do not, by themselves, establish cause, eliminate selection effects or turn a questionnaire into a diagnostic assessment.
- A cross-sectional association has no established timeline. These analyses cannot determine whether emotional symptoms preceded greater migraine burden, followed it or developed alongside it. The fact that CaMEO was part of a longitudinal project does not make this particular analysis longitudinal.
- Recruitment affects who is represented. An internet panel and a migraine-app registry draw participants through different routes. Neither sample automatically represents every adult with migraine. Both samples included substantially more women than men.
- Adjustment addresses measured differences, not every possible explanation. CaMEO's association remained after accounting for headache frequency and other covariates. That strengthens the finding that the observed relationship was not explained solely by those measured factors, but it does not prove causation.
The studies also measured different outcomes. CaMEO reported relative differences involving moderate or severe disability, while HeAD-US reported differences in MIDAS and MIBS scores. Comparing the size of those percentages directly would mix different outcomes and analyses. A larger number in one report does not establish a stronger underlying relationship than in the other.
Putting the findings into medical and mental-health context
The National Institute of Neurological Disorders and Stroke headache booklet explains that headaches vary in frequency, pain intensity and accompanying symptoms, such as nausea or sensitivity to light or noise. It advises talking with a doctor when headaches affect daily life. This is general headache education, not migraine-specific guidance about anxiety or depression.
That distinction matters when interpreting research. Headache characteristics and their effect on daily activities belong in medical assessment; emotional symptoms deserve attention without being assumed to explain the headache. The studies do not provide a way to diagnose an individual from a combination of headache frequency, mood symptoms and missed activities. Nor do their findings select a migraine treatment or establish which mental-health service a person needs.
In these papers, “disability” refers to measured interference with activities. It is not a determination about eligibility for disability benefits, workplace accommodations or another legal status. The research describes functional burden rather than deciding an individual's administrative or legal circumstances.
Adults considering support for emotional symptoms can explore mental health treatment in Massachusetts while keeping medical evaluation of headaches a separate part of their care. Merrimack Valley Behavioral Health offers outpatient mental-health care. Adults seeking that support can contact the practice about its services; this research summary does not establish that MVBH provides migraine diagnosis or treatment.
Reviewed by clinical staff
Frequently Asked Questions
Does migraine cause anxiety or depression?
The two analyses summarized here cannot establish that migraine causes either condition. Both used cross-sectional data, so they identify relationships without determining which symptoms came first. Anxiety and depressive symptoms were associated with greater migraine-related burden, but that finding does not establish the direction of the relationship or explain an individual person's symptoms.
Can episodic migraine still have a substantial daily impact?
Yes. Episodic classification does not mean that migraine causes little disruption. CaMEO measured activity limitations separately from headache frequency, and its analysis included adults with both episodic and chronic migraine. Although depression and anxiety screening rates were higher in the chronic group, those group differences do not determine how much difficulty any one person experiences.
What does between-attack burden mean?
Between-attack burden, also called interictal burden, concerns migraine-related burden outside attacks themselves. HeAD-US measured it using MIBS, separately from MIDAS disability scores. Anxiety and depressive symptoms were associated with higher MIBS scores. The abstract does not provide enough detail to assign particular between-attack experiences to an individual or explain why their burden occurs.
Do these percentages describe adults in Massachusetts?
No. The reported percentages belong to the study samples, not to a Massachusetts prevalence survey. CaMEO recruited through an internet research panel, while HeAD-US recruited through a migraine app. Their participant characteristics and screening methods matter. Neither study supports using its group rates as the probability that a particular Massachusetts adult has anxiety or depression.
Do these studies prove that addressing depression will reduce migraine disability?
No. An association between depressive symptoms and disability is not evidence that a particular intervention will reduce disability. These analyses did not establish that treatment effect. Emotional symptoms can still merit their own assessment, but the findings should not be converted into a promise about migraine improvement or a recommendation for a specific treatment.